ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000018661
Date of registration:	14/08/2015
Prospective Registration:	Yes
Primary sponsor:	Kobe City Medical Center General Hospital
Public title:	Neoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PII
Scientific title:	Neoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PII - Neo G-SOX PII study
Date of first enrolment:	2015/08/14
Target sample size:	40
Recruitment status:	Complete: follow-up continuing
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021603
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Yoshihiro Okita
Address:	1750-1, Ikenobe, Miki-cho, Kita-gun, Kagawa 7610701 Japan
Telephone:	087-898-5111
Email:	yokita@med.kagawa-u.ac.jp
Affiliation:	Kagawa University Hospital Department of Clinical Oncology

Name:	Hironaga Satake
Address:	2-1-1, Minatojima minamimachi,chuo-ku,Kobe city,Hyogo Japan
Telephone:	078-302-4321
Email:	takeh1977@gmail.com
Affiliation:	Kobe City Medical Center General Hospital Department of Medical Oncology

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: 1) active synchronous or metachronous malignancy other than carcinoma in situ 2) pregnant or nursing 3) severe mental disorders 4) uncontrolled diabetes mellitus 5) history of myocardial infarction, unstable angina within 3 months prior to the registration 6) serious coexisting illness 7) active infection 8) peripheral neuropathy greater than Grade 2 9) ileus 10) massive pleural effusion or ascites

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

gastric cancer

Intervention(s)

2course of S-1/oxaliplatin

Primary Outcome(s)

curative resection rate

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

none

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

rinken@kcho.jp

Kobe City Medical Center General Hospital

0783024321

rinken@kcho.jp

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.